Allakos Future Growth
Future criteria checks 0/6
Allakos is forecast to grow earnings and revenue by 45.4% and 80.3% per annum respectively while EPS is expected to grow by 54.5% per annum.
Key information
45.4%
Earnings growth rate
54.5%
EPS growth rate
| Biotechs earnings growth | 21.1% |
| Revenue growth rate | 80.3% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 25 Mar 2024 |
Recent future growth updates
Recent updates
We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
Dec 01
Companies Like Allakos (NASDAQ:ALLK) Are In A Position To Invest In Growth
Aug 03Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Apr 20Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 04Allakos: Potential For Comeback With Lirentelimab With 2 Indications
Oct 18Allakos prices ~$150M underwritten offering
Sep 19Allakos falls as lead asset offers mixed results in late-stage trial
Sep 09Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely
Aug 06Will Allakos (NASDAQ:ALLK) Spend Its Cash Wisely?
Apr 22Allakos: Sad End To A Promising Asset
Dec 23We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
Dec 01We Think Allakos (NASDAQ:ALLK) Can Afford To Drive Business Growth
Aug 16Allakos: Upcoming Phase 3 Data Makes The Stock Interesting
Aug 06Allakos provides lirentelimab clinical trial enrollment updates, names new CMO
Jun 07We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely
May 02Have Allakos Inc. (NASDAQ:ALLK) Insiders Been Selling Their Stock?
Mar 10Allakos Inc. (NASDAQ:ALLK) Insiders Have Been Selling
Jan 28
We're Interested To See How Allakos (NASDAQ:ALLK) Uses Its Cash Hoard To Grow
Dec 07Allakos EPS misses by $0.02
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -88 | -100 | N/A | 5 |
| 12/31/2025 | N/A | -76 | -98 | N/A | 7 |
| 12/31/2024 | N/A | -106 | N/A | N/A | 7 |
| 12/31/2023 | N/A | -186 | -117 | -116 | N/A |
| 9/30/2023 | N/A | -166 | -140 | -139 | N/A |
| 6/30/2023 | N/A | -151 | -139 | -136 | N/A |
| 3/31/2023 | N/A | -165 | -142 | -136 | N/A |
| 12/31/2022 | N/A | -320 | -288 | -280 | N/A |
| 9/30/2022 | N/A | -371 | -322 | -299 | N/A |
| 6/30/2022 | N/A | -403 | -350 | -319 | N/A |
| 3/31/2022 | N/A | -411 | -371 | -336 | N/A |
| 12/31/2021 | N/A | -270 | -241 | -208 | N/A |
| 9/30/2021 | N/A | -220 | -195 | -177 | N/A |
| 6/30/2021 | N/A | -199 | -174 | -166 | N/A |
| 3/31/2021 | N/A | -181 | -143 | -142 | N/A |
| 12/31/2020 | N/A | -153 | -115 | -114 | N/A |
| 9/30/2020 | N/A | -134 | -99 | -99 | N/A |
| 6/30/2020 | N/A | -113 | -79 | -79 | N/A |
| 3/31/2020 | N/A | -93 | -69 | -68 | N/A |
| 12/31/2019 | N/A | -85 | -64 | -63 | N/A |
| 9/30/2019 | N/A | -75 | -60 | -57 | N/A |
| 6/30/2019 | N/A | -65 | -55 | -49 | N/A |
| 3/31/2019 | N/A | -55 | -49 | -42 | N/A |
| 12/31/2018 | N/A | -44 | -45 | -38 | N/A |
| 9/30/2018 | N/A | -37 | -38 | -33 | N/A |
| 6/30/2018 | N/A | -32 | -32 | -30 | N/A |
| 3/31/2018 | N/A | -27 | -27 | -26 | N/A |
| 12/31/2017 | N/A | -24 | -23 | -23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALLK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALLK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALLK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALLK is forecast to have no revenue next year.
High Growth Revenue: ALLK is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALLK's Return on Equity is forecast to be high in 3 years time